Aprecia Pharmaceuticals Stock
Aprecia Pharmaceuticals develops precision drug delivery systems and products.
Sign up today and learn more about Aprecia Pharmaceuticals Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Aprecia Pharmaceuticals Stock
Aprecia Pharmaceuticals Company develops and manufactures precision drug delivery systems and products. Its products include CustomRelease that provides various time release profiles; ZipDose, a orally dispersing wafers pairing a high dose ceiling with times, taste-masking options, and IR/ER combinations; and NanoDose that is suited for products requiring submilligram doses. The company also offers ImplantaDose, which is suited for post surgical management of infections and associated pain, and sequential release of biomimetic proteins and peptides. Aprecia Pharmaceuticals Company was incorproated in 2003 and is based in Langhorne, Pennsylvania.
Funding History
| May 2007 | $139K |
|---|---|
| May 2009 | $500K |
| January 2010 | $5.5M |
| December 2010 | $3.9M |
| November 2011 | $25.7M |
| November 2012 | $4.0M |
| December 2013 | $14.9M |
| August 2015 | $38.8M |
| January 2016 | $35.0M |
| July 2016 | $30.0M |
Management
President and Chief Scientist
Donald Monkhouse
Executive Director
Lawrence Glassmann
Chairman
Etienne Perold
CEO
Don Wetherhold
Executive Director
E. Thomas Arington
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
